Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

Similar articles for PubMed (Select 22147735)

1.

Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers.

Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, Fleming ST, Morris CR, Huang B, Trentham-Dietz A, Lipscomb J.

J Clin Oncol. 2012 Jan 10;30(2):142-50. doi: 10.1200/JCO.2011.36.8399. Epub 2011 Dec 5.

2.

The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.

Freedman RA, Virgo KS, He Y, Pavluck AL, Winer EP, Ward EM, Keating NL.

Cancer. 2011 Jan 1;117(1):180-9. doi: 10.1002/cncr.25542. Epub 2010 Oct 11.

3.

Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998-2005).

Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E.

J Natl Cancer Inst. 2008 Apr 2;100(7):462-74. doi: 10.1093/jnci/djn057. Epub 2008 Mar 25.

4.

Social and racial differences in selection of breast cancer adjuvant chemotherapy regimens.

Griggs JJ, Culakova E, Sorbero ME, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.

J Clin Oncol. 2007 Jun 20;25(18):2522-7.

5.

Effect of patient socioeconomic status and body mass index on the quality of breast cancer adjuvant chemotherapy.

Griggs JJ, Culakova E, Sorbero ME, van Ryn M, Poniewierski MS, Wolff DA, Crawford J, Dale DC, Lyman GH.

J Clin Oncol. 2007 Jan 20;25(3):277-84. Epub 2006 Dec 11.

6.

Disparities in ovarian cancer care quality and survival according to race and socioeconomic status.

Bristow RE, Powell MA, Al-Hammadi N, Chen L, Miller JP, Roland PY, Mutch DG, Cliby WA.

J Natl Cancer Inst. 2013 Jun 5;105(11):823-32. doi: 10.1093/jnci/djt065. Epub 2013 Mar 28.

7.

The roles of teaching hospitals, insurance status, and race/ethnicity in receipt of adjuvant therapy for regional-stage breast cancer in Florida.

Richardson LC, Tian L, Voti L, Hartzema AG, Reis I, Fleming LE, Mackinnon J.

Am J Public Health. 2006 Jan;96(1):160-6. Epub 2005 Nov 29.

8.
9.

Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample.

Griggs JJ, Hawley ST, Graff JJ, Hamilton AS, Jagsi R, Janz NK, Mujahid MS, Friese CR, Salem B, Abrahamse PH, Katz SJ.

J Clin Oncol. 2012 Sep 1;30(25):3058-64. doi: 10.1200/JCO.2012.41.9564. Epub 2012 Aug 6.

10.

Disparities in breast cancer prognostic factors by race, insurance status, and education.

DeSantis C, Jemal A, Ward E.

Cancer Causes Control. 2010 Sep;21(9):1445-50. doi: 10.1007/s10552-010-9572-z. Epub 2010 May 27.

PMID:
20506039
11.

Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States.

Bilimoria KY, Balch CM, Wayne JD, Chang DC, Palis BE, Dy SM, Lange JR.

J Clin Oncol. 2009 Apr 10;27(11):1857-63. doi: 10.1200/JCO.2008.18.7567. Epub 2009 Mar 9.

12.

Black-white differences in receipt and completion of adjuvant chemotherapy among breast cancer patients in a rural region of the US.

Lipscomb J, Gillespie TW, Goodman M, Richardson LC, Pollack LA, Ryerson AB, Ward KC.

Breast Cancer Res Treat. 2012 May;133(1):285-96. doi: 10.1007/s10549-011-1916-1. Epub 2012 Jan 26.

PMID:
22278190
13.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
14.

Receipt of adjuvant systemic therapy among patients with high-risk breast cancer detected by mammography screening.

Bucchi L, Foca F, Ravaioli A, Vattiato R, Balducci C, Fabbri C, Cordaro C, Montanari E, Ravegnani M, Vitali B, Sangiorgi D, Leoni M, Falcini F.

Breast Cancer Res Treat. 2009 Feb;113(3):559-66. doi: 10.1007/s10549-008-9950-3. Epub 2008 Mar 4.

PMID:
18317924
15.

Treatment patterns for stage III colon cancer and factors related to receipt of postoperative chemotherapy in Louisiana.

Wu X, Chen VW, Andrews PA, Chen L, Hsieh M, Fontham ET.

J La State Med Soc. 2004 Sep-Oct;156(5):255-61.

PMID:
15554095
16.

The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida.

Voti L, Richardson LC, Reis I, Fleming LE, Mackinnon J, Coebergh JW.

Breast Cancer Res Treat. 2006 Jan;95(1):89-95. Epub 2005 Oct 22.

PMID:
16244785
17.

Insurance status and the use of guideline therapy in the treatment of selected cancers.

Harlan LC, Greene AL, Clegg LX, Mooney M, Stevens JL, Brown ML.

J Clin Oncol. 2005 Dec 20;23(36):9079-88. Epub 2005 Nov 21.

18.

Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006.

Fedewa SA, Ward EM, Stewart AK, Edge SB.

J Clin Oncol. 2010 Sep 20;28(27):4135-41. doi: 10.1200/JCO.2009.27.2427. Epub 2010 Aug 9.

19.

Breast cancer treatment guidelines in older women.

Giordano SH, Hortobagyi GN, Kau SW, Theriault RL, Bondy ML.

J Clin Oncol. 2005 Feb 1;23(4):783-91.

20.

A tracking and feedback registry to reduce racial disparities in breast cancer care.

Bickell NA, Shastri K, Fei K, Oluwole S, Godfrey H, Hiotis K, Srinivasan A, Guth AA.

J Natl Cancer Inst. 2008 Dec 3;100(23):1717-23. doi: 10.1093/jnci/djn387. Epub 2008 Nov 25.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk